(HealthDay News) — Among patients with type 2 diabetes, vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate and has no effect on blood pressure during ...
Please provide your email address to receive an email when new articles are posted on . In addition, those participants who received vildagliptin earlier in treatment were more successful in ...
Novartis announced the key results from the phase IV clinical study VERIFY evaluating the long-term efficacy and safety of early combination treatment strategy with metformin plus vildagliptin ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The DPP-IV inhibitor vildagliptin and metformin may both ...
LONDON (MarketWatch) -- Novartis AG , ahead of a research-and-development presentation, said Phase III data on its vildagliptin diabetes candidate and aliskiren blood pressure drug support regulatory ...